8YK4 | pdb_00008yk4

Structure of SARS-CoV-2 RBD and antibody NT-108


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free: 
    0.267 (Depositor), 0.236 (DCC) 
  • R-Value Work: 
    0.243 (Depositor) 
  • R-Value Observed: 
    0.244 (Depositor) 

Starting Model: in silico
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8YK4

This is version 1.0 of the entry. See complete history

Literature

Structural Basis for Potent Neutralization Activity of SARS-CoV-2 Antibody, NT-108

Anraku, Y.Tadokoro, T.Suzuki, T.Sasaki, J.Hashiguchi, T.Kita, S.Shiwa, N.Iwata, N.Nagata, N.Suzuki, T.Kazuki, Y.Fukuhara, H.Oshimura, M.Sato, A.Sasaki, M.Orba, Y.Sawa, H.Maenaka, K.

To be published.

Macromolecule Content 

  • Total Structure Weight: 54.02 kDa 
  • Atom Count: 3,179 
  • Modeled Residue Count: 408 
  • Deposited Residue Count: 497 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
antibody NT-108, single chain Fv fragment282Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Spike protein S1B [auth C]215Severe acute respiratory syndrome coronavirus 2Mutation(s): 0 
UniProt
Find proteins for A0A7U3DZD0 (Severe acute respiratory syndrome coronavirus 2)
Explore A0A7U3DZD0 
Go to UniProtKB:  A0A7U3DZD0
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A7U3DZD0
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.20 Å
  • R-Value Free:  0.267 (Depositor), 0.236 (DCC) 
  • R-Value Work:  0.243 (Depositor) 
  • R-Value Observed: 0.244 (Depositor) 
Space Group: I 2 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 55.152α = 90
b = 149.641β = 90
c = 253.429γ = 90
Software Package:
Software NamePurpose
XDSdata reduction
Aimlessdata scaling
PHENIXrefinement

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Japan Agency for Medical Research and Development (AMED)JapanJP20fk0108298
Japan Agency for Medical Research and Development (AMED)JapanJP20ae0101047
Japan Agency for Medical Research and Development (AMED)JapanJP20am0101093

Revision History  (Full details and data files)

  • Version 1.0: 2025-03-12
    Type: Initial release